Having rational data upon which to base recommendations for when reasonably to stop cancer screening is important from both an individual patient and public health perspective. Previous studies using the MISCAN-colon model have taken into account both age and co-morbidities without fulling accounting for variation in prior screening. In this issue of CGH, Cenin et al. demonstrate that prior screening history and comorbidities greatly influence appropriate stopping ages for colorectal cancer screening, with ages ranging from 66 to 90. The study adds further data to support the individualization rather than a “one size fits all” approach to stopping ages for CRC screening. It also highlights the importance of obtaining a full screening history, including getting old records if necessary, and the need for simple and efficient ways to implement data into clinical practice in order for information regarding tailoring of CRC screening to translate into tangible population health benefits.
CRC (colorectal cancer), EMR (electronic medical record), FIT (fecal immunochemical testing), MISCAN (Microsimulation SCreening Analysis), US (Preventive Services Task Force (USPSTF))
In Press Journal Pre-Proof
Disclosures: No conflicts of interest
© 2020 by the AGA Institute
Access this article on ScienceDirect